Celia J Winchell

  • Citations Per Year
Learn More
Researchers working in the field of clinical trials for addictive disorders have discussed whether the use of responder analyses (analyses which compare the proportion of patients in each treatment arm who achieve the desired response) in these trials represents “setting the bar too high.” These discussions involve assumptions about the relative ease or(More)
In their article, “Addressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco,” Fucito et al.1 call for further revisions to labeling of over-the-counter nicotine replacement therapy products (NRT)(More)
  • 1